{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:14:56Z","timestamp":1790273696416,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.antiviral.2008.12.004","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T09:34:55Z","timestamp":1230716095000},"page":"239-247","source":"Crossref","is-referenced-by-count":34,"title":["High-throughput screening using pseudotyped lentiviral particles: A strategy for the identification of HIV-1 inhibitors in a cell-based assay"],"prefix":"10.1016","volume":"81","author":[{"given":"Jean-Michel","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bruzzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Jun","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Altmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ymthe.2006.03.007","article-title":"Retrovirus vectors: toward the plentivirus?","volume":"13","author":"Baum","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00063030-200721010-00003","article-title":"RNAi therapy for HIV infection: principles and practicalities","volume":"21","author":"Bennasser","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.antiviral.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1128\/JVI.00919-06","article-title":"Nonsegmented negative-strand viruses as vaccine vectors","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1073\/pnas.90.17.8033","article-title":"Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells","volume":"90","author":"Burns","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.12.004_bib5","first-page":"253","article-title":"Screening of HIV-1 replication inhibitors by using pseudotyped virus system","volume":"43","author":"Cao","year":"2008","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.antiviral.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1087057106288881","article-title":"Development of a Moloney murine leukemia virus-based pseudotype anti-HIV assay suitable for accurate and rapid evaluation of HIV entry inhibitors","volume":"11","author":"Chan","year":"2006","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.antiviral.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0092-8674(01)00418-4","article-title":"Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses","volume":"106","author":"Chan","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1128\/JVI.68.2.1179-1185.1994","article-title":"Fusion from without directed by human immunodeficiency virus particles","volume":"68","author":"Clavel","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.318.5853.1048","article-title":"Did Merck's failed HIV vaccine cause harm?","volume":"318","author":"Cohen","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/science.318.5847.28","article-title":"Promising AIDS vaccine's failure leaves field reeling","volume":"318","author":"Cohen","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1099\/vir.0.81710-0","article-title":"Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis","volume":"87","author":"Codran","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A","article-title":"Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection","volume":"20","author":"De Clercq","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.73.4.3455-3459.1999","article-title":"Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivity","volume":"73","author":"de la Carri\u00e8re","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(07)61052-6","article-title":"HIV entry inhibitors","volume":"370","author":"Est\u00e9","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2008.12.004_bib16","article-title":"A sensitive method for the detection of beta-galactosidase in transfected mammalian cells","volume":"11","author":"Eustice","year":"1991","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.clpt.6100141","article-title":"Nuclear transport: target for therapy","volume":"81","author":"Faustino","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nrd2336","article-title":"HIV drug development: the next 25 years","volume":"6","author":"Flexner","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jmv.20732","article-title":"Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody response to SARS-CoV","volume":"78","author":"Fukushi","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.96.23.13040","article-title":"Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design","volume":"96","author":"Goldgur","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0065-3527(00)55017-9","article-title":"Retroviral vectors","volume":"55","author":"Kim","year":"2000","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2008.12.004_bib22","first-page":"659","article-title":"Structure-activity relationships of 1\u2032-acetoxychavicol acetate homologues as new nuclear export signal inhibitors","volume":"62","author":"Liu","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.antiviral.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1087057103256465","article-title":"A simple technique for reducing edge effect in cell-based assays","volume":"8","author":"Lundholt","year":"2003","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.antiviral.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-1702(99)00070-2","article-title":"Murine leukemia virus pseudotypes of La Crosse and Hantaan bunyaviruses: a system for analysis of cell tropism","volume":"64","author":"Ma","year":"1999","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/JVI.72.3.2208-2212.1998","article-title":"Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1","volume":"72","author":"Mar\u00e9chal","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/0022-1317-68-9-2359","article-title":"Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH","volume":"68","author":"Mastromarino","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1348-0421.1998.tb02288.x","article-title":"Human immunodeficiency virus type 1 (HIV-1) infection and transcytosis activity of a HIV-1 susceptible clone from HeLa cell","volume":"42","author":"Morizono","year":"1998","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/088922204322749567","article-title":"The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection","volume":"20","author":"Moore","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.bmcl.2006.02.024","article-title":"Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant","volume":"16","author":"Muraglia","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2007.02.005","article-title":"Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis","volume":"39","author":"Nefkens","year":"2007","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2006.07.006","article-title":"A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals","volume":"73","author":"Noah","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0076-6879(00)26055-2","article-title":"Novel methods for chemiluminescent detection of reporter enzymes","volume":"326","author":"Olesen","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/viro.2001.0984","article-title":"Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes","volume":"286","author":"Petit","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.12.004_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1099-1654(200007\/08)10:4<231::AID-RMV290>3.0.CO;2-P","article-title":"Incidence and impact of resistance against approved antiretroviral drugs","volume":"10","author":"Pillay","year":"2000","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib37","doi-asserted-by":"crossref","unstructured":"Ritz, C., Streibig, J.C., 2005. Bioassay Analysis using R.J. Statist Software, vol. 12, issue 5.","DOI":"10.18637\/jss.v012.i05"},{"key":"10.1016\/j.antiviral.2008.12.004_bib38","first-page":"162","article-title":"Maturation inhibitors: a new therapeutic class targets the virus structure","volume":"9","author":"Salzwedel","year":"2007","journal-title":"AIDS Rev."},{"key":"10.1016\/j.antiviral.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/JVI.69.7.4053-4059.1995","article-title":"Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell","volume":"69","author":"Schwartz","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jana.2006.11.012","article-title":"Long-term suppression of HIV infection: benefits and limitations of current treatment options","volume":"18","author":"Sension","year":"2007","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"10.1016\/j.antiviral.2008.12.004_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.emboj.7601509","article-title":"ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation","volume":"26","author":"Sol-Foulon","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2008.12.004_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1310\/06DD-UN4D-9AW2-RLBY","article-title":"Genetic mechanisms of resistance to NRTI and NNRTI","volume":"3","author":"Soriano","year":"2002","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.antiviral.2008.12.004_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157016206776055048","article-title":"Dynamics of virus-host interplay in HIV-1 replication","volume":"4","author":"Sorin","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.antiviral.2008.12.004_bib44","unstructured":"UNAIDS\/WHO, 2007. AIDS Epidemic Update, December 2007, Geneva."},{"key":"10.1016\/j.antiviral.2008.12.004_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/excr.2000.4908","article-title":"Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells","volume":"258","author":"Watanabe","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.antiviral.2008.12.004_bib46","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib47","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2005.11.021","article-title":"Update on HAART in HIV","volume":"44","author":"Yeni","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2008.12.004_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/157016207781023965","article-title":"HIV-1 integrase: from biology to chemotherapeutics","volume":"5","author":"Zeinalipour-Loizidou","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.antiviral.2008.12.004_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208004609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208004609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:25:24Z","timestamp":1589441124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208004609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0166354208004609"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.12.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}